Screener
Fulgent Genetics, Inc. FLGT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| In-process research & development | 68,490 | 68,490 |
| Other intangible assets, net | 85,499 | 64,791 |
| Goodwill | 53,731 | 25,080 |
| Other long-term assets | 24,976 | 22,856 |
| Total assets | $1,156,369 | $1,213,525 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $21,125 | $18,654 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets?
- Fulgent Genetics, Inc. (FLGT) reported deferred tax assets and other non-current assets of $24.98M in Q1 2026.
- How has Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets decreased by 23.6% year-over-year, from $32.71M to $24.98M.
- What is the long-term trend for Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets has grown at a 40.7% compound annual growth rate (CAGR), from $4.14M to $22.86M.
Ask your AI about Fulgent Genetics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude